Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox

Peter B. Jahrling, Lisa E. Hensley, Mark J. Martinez, James LeDuc, Kathleen H. Rubins, David A. Relman, John W. Huggins

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Smallpox virus (variola) poses a significant threat as an agent of bioterrorism. To mitigate this risk, antiviral drugs and an improved vaccine are urgently needed. Satisfactory demonstration of protective efficacy against authentic variola will require development of an animal model in which variola produces a disease course with features consistent with human smallpox. Toward this end, cynomolgus macaques were exposed to several variola strains through aerosol and/or i.v. routes. Two strains, Harper and India 7124, produced uniform acute lethality when inoculated i.v. in high doses (109 plaque-forming units). Lower doses resulted in less fulminant, systemic disease and lower mortality. Animals that died had profound leukocytosis, thrombocytopenia, and elevated serum creatinine levels. After inoculation, variola was disseminated by means of a monocytic cell-associated viremia. Distribution of viral antigens by immunohistochemistry correlated with the presence of replicating viral particles demonstrated by electron microscopy and pathology in the lymphoid tissues, skin, oral mucosa, gastrointestinal tract, reproductive system, and liver. These particles resembled those seen in human smallpox. High viral burdens in target tissues were associated with organ dysfunction and multisystem failure. Evidence of coagulation cascade activation (D dimers) corroborated histologic evidence of hemorrhagic diathesis. Depletion of T cell-dependent areas of lymphoid tissues occurred, probably as a consequence of bystander apoptotic mechanisms initiated by infected macrophages. Elaboration of cytokines, including IL-6 and IFN-γ, contribute to a cytokine storm formerly known as "toxemia." A more precise understanding of disease pathogenesis should provide targets for therapeutic intervention, to be used alone or in combination with inhibitors of variola virus replication.

Original languageEnglish (US)
Pages (from-to)15196-15200
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number42
DOIs
StatePublished - Oct 19 2004
Externally publishedYes

Fingerprint

Variola virus
Smallpox
Macaca
Virus Diseases
Lymphoid Tissue
Biological Warfare Agents
Cytokines
Hemorrhagic Disorders
Toxemia
Viral Antigens
Viremia
Leukocytosis
Mouth Mucosa
Virus Replication
Aerosols
Viral Load
Thrombocytopenia
Virion
Antiviral Agents
Gastrointestinal Tract

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. / Jahrling, Peter B.; Hensley, Lisa E.; Martinez, Mark J.; LeDuc, James; Rubins, Kathleen H.; Relman, David A.; Huggins, John W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 42, 19.10.2004, p. 15196-15200.

Research output: Contribution to journalArticle

Jahrling, Peter B. ; Hensley, Lisa E. ; Martinez, Mark J. ; LeDuc, James ; Rubins, Kathleen H. ; Relman, David A. ; Huggins, John W. / Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 42. pp. 15196-15200.
@article{af149edffbbd4fb58323e068513dcf47,
title = "Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox",
abstract = "Smallpox virus (variola) poses a significant threat as an agent of bioterrorism. To mitigate this risk, antiviral drugs and an improved vaccine are urgently needed. Satisfactory demonstration of protective efficacy against authentic variola will require development of an animal model in which variola produces a disease course with features consistent with human smallpox. Toward this end, cynomolgus macaques were exposed to several variola strains through aerosol and/or i.v. routes. Two strains, Harper and India 7124, produced uniform acute lethality when inoculated i.v. in high doses (109 plaque-forming units). Lower doses resulted in less fulminant, systemic disease and lower mortality. Animals that died had profound leukocytosis, thrombocytopenia, and elevated serum creatinine levels. After inoculation, variola was disseminated by means of a monocytic cell-associated viremia. Distribution of viral antigens by immunohistochemistry correlated with the presence of replicating viral particles demonstrated by electron microscopy and pathology in the lymphoid tissues, skin, oral mucosa, gastrointestinal tract, reproductive system, and liver. These particles resembled those seen in human smallpox. High viral burdens in target tissues were associated with organ dysfunction and multisystem failure. Evidence of coagulation cascade activation (D dimers) corroborated histologic evidence of hemorrhagic diathesis. Depletion of T cell-dependent areas of lymphoid tissues occurred, probably as a consequence of bystander apoptotic mechanisms initiated by infected macrophages. Elaboration of cytokines, including IL-6 and IFN-γ, contribute to a cytokine storm formerly known as {"}toxemia.{"} A more precise understanding of disease pathogenesis should provide targets for therapeutic intervention, to be used alone or in combination with inhibitors of variola virus replication.",
author = "Jahrling, {Peter B.} and Hensley, {Lisa E.} and Martinez, {Mark J.} and James LeDuc and Rubins, {Kathleen H.} and Relman, {David A.} and Huggins, {John W.}",
year = "2004",
month = "10",
day = "19",
doi = "10.1073/pnas.0405954101",
language = "English (US)",
volume = "101",
pages = "15196--15200",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "42",

}

TY - JOUR

T1 - Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox

AU - Jahrling, Peter B.

AU - Hensley, Lisa E.

AU - Martinez, Mark J.

AU - LeDuc, James

AU - Rubins, Kathleen H.

AU - Relman, David A.

AU - Huggins, John W.

PY - 2004/10/19

Y1 - 2004/10/19

N2 - Smallpox virus (variola) poses a significant threat as an agent of bioterrorism. To mitigate this risk, antiviral drugs and an improved vaccine are urgently needed. Satisfactory demonstration of protective efficacy against authentic variola will require development of an animal model in which variola produces a disease course with features consistent with human smallpox. Toward this end, cynomolgus macaques were exposed to several variola strains through aerosol and/or i.v. routes. Two strains, Harper and India 7124, produced uniform acute lethality when inoculated i.v. in high doses (109 plaque-forming units). Lower doses resulted in less fulminant, systemic disease and lower mortality. Animals that died had profound leukocytosis, thrombocytopenia, and elevated serum creatinine levels. After inoculation, variola was disseminated by means of a monocytic cell-associated viremia. Distribution of viral antigens by immunohistochemistry correlated with the presence of replicating viral particles demonstrated by electron microscopy and pathology in the lymphoid tissues, skin, oral mucosa, gastrointestinal tract, reproductive system, and liver. These particles resembled those seen in human smallpox. High viral burdens in target tissues were associated with organ dysfunction and multisystem failure. Evidence of coagulation cascade activation (D dimers) corroborated histologic evidence of hemorrhagic diathesis. Depletion of T cell-dependent areas of lymphoid tissues occurred, probably as a consequence of bystander apoptotic mechanisms initiated by infected macrophages. Elaboration of cytokines, including IL-6 and IFN-γ, contribute to a cytokine storm formerly known as "toxemia." A more precise understanding of disease pathogenesis should provide targets for therapeutic intervention, to be used alone or in combination with inhibitors of variola virus replication.

AB - Smallpox virus (variola) poses a significant threat as an agent of bioterrorism. To mitigate this risk, antiviral drugs and an improved vaccine are urgently needed. Satisfactory demonstration of protective efficacy against authentic variola will require development of an animal model in which variola produces a disease course with features consistent with human smallpox. Toward this end, cynomolgus macaques were exposed to several variola strains through aerosol and/or i.v. routes. Two strains, Harper and India 7124, produced uniform acute lethality when inoculated i.v. in high doses (109 plaque-forming units). Lower doses resulted in less fulminant, systemic disease and lower mortality. Animals that died had profound leukocytosis, thrombocytopenia, and elevated serum creatinine levels. After inoculation, variola was disseminated by means of a monocytic cell-associated viremia. Distribution of viral antigens by immunohistochemistry correlated with the presence of replicating viral particles demonstrated by electron microscopy and pathology in the lymphoid tissues, skin, oral mucosa, gastrointestinal tract, reproductive system, and liver. These particles resembled those seen in human smallpox. High viral burdens in target tissues were associated with organ dysfunction and multisystem failure. Evidence of coagulation cascade activation (D dimers) corroborated histologic evidence of hemorrhagic diathesis. Depletion of T cell-dependent areas of lymphoid tissues occurred, probably as a consequence of bystander apoptotic mechanisms initiated by infected macrophages. Elaboration of cytokines, including IL-6 and IFN-γ, contribute to a cytokine storm formerly known as "toxemia." A more precise understanding of disease pathogenesis should provide targets for therapeutic intervention, to be used alone or in combination with inhibitors of variola virus replication.

UR - http://www.scopus.com/inward/record.url?scp=6344282192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6344282192&partnerID=8YFLogxK

U2 - 10.1073/pnas.0405954101

DO - 10.1073/pnas.0405954101

M3 - Article

VL - 101

SP - 15196

EP - 15200

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 42

ER -